Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...

As the first immunotherapy option in this setting, the approval sets a new standard for resectable early-stage gastric and gastroesophageal junction (GEJ) cancers.

A retrospective cohort study in the Netherlands evaluated the real-world effectiveness of the biosimilar adalimumab Hyrimoz ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.

Pirtobrutinib is now FDA-approved for relapsed/refractory CLL/SLL after prior covalent BTK inhibitor therapy, following its 2023 accelerated approval. The BRUIN-CLL-321 trial showed pirtobrutinib ...

Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says ...

Despite the impact of targeted treatment in oncology, much work remains to bring these therapeutics to all patients, says Bhavana (Tina) Bhatnagar, DO.

Reduced costly care: Behavioral health–related emergency department visits and inpatient admissions decreased by 35% and 43%, respectively. Lower total medical costs: The intervention group saved ...

Graff: The biggest benefit of these DTC models is [they] reduce the friction for any patient trying to receive care. It solves the problem and the multiple months in their treatment journey to receive ...

Ben Light is the vice president of partnerships at Zorro, a vendor of Individual Coverage Health Reimbursement Arrangements (ICHRAs), and an expert in ICHRAs. With ACA subsidies ending in 2025, Ben ...

The frequency of blinking can affect the stability of tear film in those living with dry eye, with the threshold of 20 blinks ...

Peter Voorhees, MD, explains how daratumumab and hyaluronidase-fihj show superior efficacy in delaying progression of MM ...